In 1994 Matutes et al developed a scoring system for the diagnosis of CLL which is based on the immunophenotyping analysis of five markers CD5, CD23, FMC7, CD79b/CD22, and surface membrane immunoglobulin (SmIg). The gene discussed is MS4A1; the disease is B-cell chronic lymphocytic leukemia.